Nerve block may cut opioid use after robotic colorectal surgery
NCT ID NCT07185607
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested whether a nerve block called the erector spinae plane block (ESPB) can reduce pain and the need for opioids after robotic colorectal surgery. 70 patients with colorectal cancer were enrolled. The block is a simple ultrasound-guided injection near the spine. Researchers measured pain scores and total opioid use in the first 24 hours after surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Erector spinae plane block (ESPB) - a regional anesthesia procedure
- What this could lead to
- If effective, this nerve block could become a standard way to manage pain after robotic colorectal surgery, reducing opioid use and speeding recovery.
- What could go wrong
- This is a small, single-center study with no blinding or placebo control. Results may not apply to all patients or surgeries, and the block carries rare risks like bleeding or infection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Basaksehir Cam ve Sakura City Hospital
Istanbul, 34480, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a plasma beam stop colon polyps from coming back?
- A stitch in time: could a device make abdominal closure safer?
- Can we predict chemo brain before it happens?
- Your gut bacteria might reveal hidden cancer risk
- Can a smart digital program restore sleep for cancer survivors?
- Can a new infusion drug shrink Hard-to-Treat tumors?